Halneuron
HAL-CINP-203
Phase 2 small_molecule active
Quick answer
Halneuron for Chemotherapy Induced Neuropathic Pain is a Phase 2 program (small_molecule) at Dogwood Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Dogwood Therapeutics
- Indication
- Chemotherapy Induced Neuropathic Pain
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active